Paper32166319
The Integrase Inhibitors Dolutegravir and Raltegravir Exert Proadipogenic and Profibrotic Effects and Induce Insulin Resistance in Human/Simian Adipose Tissue and Human Adipocytes.
Gorwood J and 16 others. Clin Infect Dis, 2020. Cited by 136 papers, by iCite.
Cite this record
ConductScience Library. The Integrase Inhibitors Dolutegravir and Raltegravir Exert Proadipogenic and Profibrotic Effects and Induce Insulin Resistance in Human/Simian Adipose Tissue and Human Adipocytes. Papers, record 32166319. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32166319
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Integrase Inhibitors Dolutegravir and Raltegravir Exert Proadipogenic and Profibrotic Effects and Induce Insulin Resistance in Human/Simian Adipose Tissue and Human Adipocytes.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| HIV Infections | Major topic |
| HIV Integrase Inhibitors | Major topic |
| Insulin Resistance | Major topic |
| Adipocytes | |
| Adipose Tissue | |
| Drug Resistance, Viral | |
| Heterocyclic Compounds, 3-Ring | |
| Humans | |
| Integrase Inhibitors | |
| Oxazines | |
| Piperazines | |
| Pyridones | |
| Raltegravir Potassium | |
| Dolutegravir |
Source PubMed
Cited by87
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 136 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42821149 | A novel synergistic phycobiliprotein combination against HIV-1 shows potent antiviral activity. | AMB Express | 2026 | https://conductscience.org/library/papers/42821149 | PubMed |
| 42819026 | Metabolic dysfunction-associated steatotic liver disease in people living with HIV: mechanisms, diagnosis, and management. | Front Immunol | 2026 | https://conductscience.org/library/papers/42819026 | PubMed |
| 42577690 | Longitudinal Hepatic and Metabolic Trajectories Following Dolutegravir Initiation in Antiretroviral Therapy (ART)-Naïve People Living With HIV: A Prospective Cohort Study From South India. | Cureus | 2026 | https://conductscience.org/library/papers/42577690 | PubMed |
| 42544255 | Dolutegravir-Associated Dyslipidemia and Atherogenic Lipid Changes Among Treatment-Naïve People Living With HIV: A 12-Month Prospective Cohort Study From Southern India. | Cureus | 2026 | https://conductscience.org/library/papers/42544255 | PubMed |
| 42471828 | Semi-automated, evidence-based workflow for selection of reference chemicals for the validation of NAMs: a case study with the adipogenesis assay. | NAM J | 2026 | https://conductscience.org/library/papers/42471828 | PubMed |
| 42467806 | Weight gain and obesity management in people with HIV: pathophysiology, antiretroviral therapy effects, and clinical strategies. | Top Antivir Med | 2026 | https://conductscience.org/library/papers/42467806 | PubMed |
| 42466959 | Dolutegravir population pharmacokinetics in racially, sex- and age-diverse and antiretroviral therapy-experienced adults with HIV in the United States. | HIV Med | 2026 | https://conductscience.org/library/papers/42466959 | PubMed |
| 42436668 | Prevalence and associated factors of malnutrition among adults living with HIV on ART: a pilot study. | Metabol Open | 2026 | https://conductscience.org/library/papers/42436668 | PubMed |
| 42378059 | A distinct form of fat fibrosis is linked to insulin resistance in people with HIV. | JCI Insight | 2026 | https://conductscience.org/library/papers/42378059 | PubMed |
| 42366600 | Longitudinal Serum Metabolomic Signatures Related to Integrase Strand Transfer Inhibitors-Associated Weight Gain in Women with HIV Enrolled in the MACS/WIHS Combined Cohort Study. | J Infect Dis | 2026 | https://conductscience.org/library/papers/42366600 | PubMed |
| 42084659 | Increased Adiposity and Dyslipidemia in Young Men Living with HIV Compared to Matched PrEP Users: A Cross-Sectional Study. | Adv Ther | 2026 | https://conductscience.org/library/papers/42084659 | PubMed |
| 41911940 | Incident diabetes after switching to integrase strand transfer inhibitors in people with HIV in the USA and Canada: a cohort study. | Lancet HIV | 2026 | https://conductscience.org/library/papers/41911940 | PubMed |
| 41880067 | To Switch or not to Switch: are there any Antiretroviral Strategies to Attenuate Weight Gain in People with HIV? | Curr HIV/AIDS Rep | 2026 | https://conductscience.org/library/papers/41880067 | PubMed |
| 41779383 | Cardiometabolic impact of dolutegravir as second-line therapy: secondary analysis of a randomized controlled trial. | AIDS | 2026 | https://conductscience.org/library/papers/41779383 | PubMed |
| 41743543 | Type 2 diabetes in people living with HIV: epidemiology, mechanisms, sex differences and early-life determinants. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/41743543 | PubMed |
| 41711779 | Combined tenofovir, lamivudine, and dolutegravir treatment increases leptin and FABP4 expression in human subcutaneous adipose tissue. | Einstein (Sao Paulo) | 2026 | https://conductscience.org/library/papers/41711779 | PubMed |
| 41600910 | Reversible Effects of Integrase Inhibitors on Newly Differentiated Adipocytes. | Viruses | 2026 | https://conductscience.org/library/papers/41600910 | PubMed |
| 41462126 | A systematic review assessing body mass index and waist circumference as predictors for the development of type 2 diabetes mellitus among people living with HIV on antiretroviral therapy. | BMC Infect Dis | 2025 | https://conductscience.org/library/papers/41462126 | PubMed |
| 41295281 | Metabolomic Profile of Weight Gain of People Living with HIV Treated with Integrase Strand Transfer Inhibitor Regimens Reveals Dysregulated Lipid Metabolism and Mitochondrial Dysfunction. | Metabolites | 2025 | https://conductscience.org/library/papers/41295281 | PubMed |
| 41252191 | Altered Lipid and Neurotransmitter Metabolism as Potential Mechanisms of Weight Gain in Women With HIV Initiating INSTIs in a Pilot Study. | J Acquir Immune Defic Syndr | 2026 | https://conductscience.org/library/papers/41252191 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ADIPOQ | 9370 | PubTator's text mining | https://conductscience.org/library/genes/9370 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32166319
GET https://conductscience.org/api/papers/v1/32166319/cited_by?page=2